DK1294372T3 - Törpulverformulering der omdanner racecadotril - Google Patents

Törpulverformulering der omdanner racecadotril

Info

Publication number
DK1294372T3
DK1294372T3 DK01969310T DK01969310T DK1294372T3 DK 1294372 T3 DK1294372 T3 DK 1294372T3 DK 01969310 T DK01969310 T DK 01969310T DK 01969310 T DK01969310 T DK 01969310T DK 1294372 T3 DK1294372 T3 DK 1294372T3
Authority
DK
Denmark
Prior art keywords
dry powder
racecadotril
transforms
powder formulation
formulation
Prior art date
Application number
DK01969310T
Other languages
Danish (da)
English (en)
Inventor
Jeanne-Marie Lecomte
Jean-Charles Schwartz
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Application granted granted Critical
Publication of DK1294372T3 publication Critical patent/DK1294372T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01969310T 2000-06-23 2001-06-22 Törpulverformulering der omdanner racecadotril DK1294372T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00401799 2000-06-23
PCT/EP2001/007086 WO2001097801A2 (en) 2000-06-23 2001-06-22 Dry powder formulation comprising racecadotril

Publications (1)

Publication Number Publication Date
DK1294372T3 true DK1294372T3 (da) 2005-09-19

Family

ID=8173739

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01969310T DK1294372T3 (da) 2000-06-23 2001-06-22 Törpulverformulering der omdanner racecadotril

Country Status (13)

Country Link
US (1) US6919093B2 (zh)
EP (1) EP1294372B1 (zh)
CN (2) CN102151247A (zh)
AT (1) ATE301999T1 (zh)
AU (1) AU2001289606A1 (zh)
BG (1) BG66212B1 (zh)
CA (1) CA2415957C (zh)
CZ (1) CZ299591B6 (zh)
DE (1) DE60112756T2 (zh)
DK (1) DK1294372T3 (zh)
ES (1) ES2247163T3 (zh)
SK (1) SK287819B6 (zh)
WO (1) WO2001097801A2 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
CN101103960B (zh) * 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
EP2462922A1 (en) 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
EP2768537B1 (en) * 2011-10-18 2019-02-20 Purdue Pharma LP Acrylic polymer formulations
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
US9114171B2 (en) 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
PT2866802T (pt) 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Composições líquidas racecadotril
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
EP2918268A1 (en) 2014-03-10 2015-09-16 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
ES2555484T1 (es) 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
EP3558272A1 (en) 2016-12-23 2019-10-30 Hermes Arzneimittel GmbH Oral pharmaceutical composition with improved taste-masking properties
WO2018163195A1 (en) 2017-03-06 2018-09-13 Athena Drug Delivery Solutions Pvt Ltd. A pharmaceutical composition comprising racecadotril and process for preparing the same
CN109589310A (zh) * 2017-10-01 2019-04-09 北京万全德众医药生物技术有限公司 消旋卡多曲干混悬剂及其制备方法
GB2586201B (en) * 2019-05-14 2023-05-24 Orbit Pharmaceuticals A stable powder formulation of racecadotril
EP4056171A1 (en) 2021-03-12 2022-09-14 Athena Pharmaceutiques SAS Taste masked racecadotril tablet composition and process for preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
EP0914822A4 (en) * 1996-03-14 2002-08-07 Bayer Ag PREPARATION OF ECADOTRIL WITH FAST MICRODISPERSION AND RELEASE
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations

Also Published As

Publication number Publication date
CN1635884A (zh) 2005-07-06
DE60112756T2 (de) 2006-06-08
CZ299591B6 (cs) 2008-09-10
DE60112756D1 (de) 2005-09-22
BG66212B1 (bg) 2012-05-31
WO2001097801A3 (en) 2002-09-12
BG107481A (bg) 2003-09-30
CZ2003185A3 (cs) 2003-05-14
CA2415957C (en) 2010-08-10
ES2247163T3 (es) 2006-03-01
CA2415957A1 (en) 2001-12-27
WO2001097801A2 (en) 2001-12-27
ATE301999T1 (de) 2005-09-15
EP1294372A2 (en) 2003-03-26
SK287819B6 (sk) 2011-11-04
AU2001289606A1 (en) 2002-01-02
US20030166718A1 (en) 2003-09-04
EP1294372B1 (en) 2005-08-17
US6919093B2 (en) 2005-07-19
CN102151247A (zh) 2011-08-17
SK762003A3 (en) 2003-07-01

Similar Documents

Publication Publication Date Title
DK1294372T3 (da) Törpulverformulering der omdanner racecadotril
DE69925133D1 (de) Pyrrolobenzodiazepine
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
ATE514418T1 (de) Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan
ID30034A (id) Aralkil amina baru dari spirofuropiridin yang berguna dalam terapi
HUP0301577A3 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
ATE275143T1 (de) Verbindungen
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
PT1263421E (pt) Avasimibe, o inibidor duplo da sintese de ester de colesterilo e de ester ceroso, para o tratamento de disturbios da glandula sebacea
RS50681B (sr) Kombinacija taksana i ciklin-zavisne kinaze
TR200002939T2 (tr) Paroksetin maleat
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
ES2159479A1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
AU2001219672A1 (en) Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections
IL152989A0 (en) Use of riluzole or its salts for preventing and treating ?noleukodystrophy
SE0001569D0 (sv) New compounds and their use in the treatment of alopecia
ECSP972253A (es) Composicion farmaceutica: nueva formulacion y su uso en el tratamiento y/o profilaxis de ciertos trastornos
FI20000549A0 (fi) Sexi-hoito ja hierontapöytä
IL137148A0 (en) Compounds and pharmaceutical compositions comprising same and their use in the field of apoptosis or cogulation
GB0023473D0 (en) Therapeutic use and formulation